跳至主要内容
临床试验/NCT05559892
NCT05559892进行中(未招募)不适用

Conditional Cash Transfer Intervention to Improve Health Outcomes Among Inner-City African Americans With T2DM

State University of New York at Buffalo1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
1
主要终点
Glycemic control (HbA1c)

研究概览

简要总结

This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in 100 inner city AAs with poorly controlled T2DM using an RCT design. The aims of the proposed study include:

AIM 1: Test the preliminary efficacy of the DM-CCT intervention on glycemic control and quality of life for inner-city AAs with T2DM.

AIM 2: Test the preliminary efficacy of the DM-CCT intervention on self-care behaviors and psychological health for inner-city AAs with T2DM.

AIM 3: Estimate the cost of delivery of the DM-CCT and UCT interventions in preparation for future cost effectiveness analysis.

详细描述

The overarching aim of this proposal is to test the preliminary efficacy of diabetes-tailored CCT (DM-CCT conditional on participating in biweekly, nurse-led, virtual diabetes education/skills training and stress/coping intervention) compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in inner city African Americans with poorly controlled T2DM. One hundred (100) individuals will be randomized to either the DM-CCT intervention or the UCT intervention and followed for 6-months, with study visits at baseline, 3-months, and 6-months. The primary outcomes will be glycemic control (HbA1c) and quality of life (SF-12) at 6-months post randomization. The secondary outcomes will be self-care behaviors (diet, exercise, medication adherence) and psychological health (stress, coping) measured at 6-months post randomization. In preparation for future cost effectiveness studies, the final aim will estimate the cost of delivery of the DM-CCT and UCT interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age ≥18 years
  • •Self-report as African American
  • •Clinical diagnosis of T2DM and HbA1c ≥8% at the screening visit
  • •Residence in inner city zip codes
  • •Income greater or equal to133% of federal poverty level or Medicaid eligible
  • •Able to communicate in English.

排除标准

  • •Mental confusion on interview suggesting significant dementia
  • •Alcohol or drug abuse/dependency
  • •Active psychosis or acute mental disorder
  • •Participation in other diabetes clinical trials
  • •Life expectancy <6 months

研究组 & 干预措施

Diabetes-Tailored CCTs (DM-CCT) Intervention

Experimental

Participants randomized to DM-CCT will receive cash transfers of $500 per month for 6 months, but the cash transfers will be conditional on attending a 60-minute diabetes education/skills training (30 minutes) and stress/coping (30 minutes) session delivered by trained nurses every 2 weeks for 6 months (12 sessions). Therefore, they will only receive cash transfer payments if they attend two sessions per month.

干预措施: DM-CCT (Behavioral)

Unconditional Cash Transfer-UCTs Intervention

Active Comparator

Participants randomized to UCT will receive cash transfers of $500 per month for 6 months, but there will be no conditions attached. Therefore, they will receive cash transfer payments every month. However, to control for content and attention, participants will receive mailed version of the diabetes education/skills training materials every two weeks on the same schedule as the DM-CCT telephone sessions.

干预措施: DM-UCT (Behavioral)

结局指标

主要结局

Glycemic control (HbA1c)

时间窗: Change from baseline HbA1c at 6 months post intervention follow-ups

Blood specimens (10cc of blood) will be obtained by trained phlebotomists or nurse for HbA1c.

Quality of Life as measured by SF-12

时间窗: Change from baseline quality of life measure at 6 months post intervention follow-ups

The SF-12 (Ware 1996) is a valid and reliable instrument to measure functional status and reproduces 90% of the variance in PCS-36 and MCS-36 scores.

次要结局

  • Self-Care(Change from baseline self-care at 6 months post intervention follow-ups)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Annette Campbell

Associate Professor

State University of New York at Buffalo

研究点 (1)

Loading locations...

相似试验